Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer
Evangelia Papadavid, Alexandros Stratigos, Matthew E. Falagas
Expert Opinion on Pharmacotherapy (2007) Vol. 8, Iss. 11, pp. 1743-1755
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Macrophage Polarization States in the Tumor Microenvironment
Ava J. Boutilier, Sherine F. Elsawa
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6995-6995
Open Access | Times Cited: 1015
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
Alain H. Rook, Joel M. Gelfand, Maria Wysocka, et al.
Blood (2015) Vol. 126, Iss. 12, pp. 1452-1461
Open Access | Times Cited: 197
Imiquimod in dermatology: an overview
Edith Hanna, Rami Abadi, Ossama Abbas
International Journal of Dermatology (2016) Vol. 55, Iss. 8, pp. 831-844
Closed Access | Times Cited: 177
Tumor-associated macrophages: an effective player of the tumor microenvironment
Udit Basak, Tania Sarkar, Sumon Mukherjee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 86
Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy
Mingqi Liu, Yang Feng, Yougong Lu, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 30
Tumor Evasion from T Cell Surveillance
Katrin Töpfer, Stefanie Kempe, Nadja Müller, et al.
BioMed Research International (2011) Vol. 2011, Iss. 1
Open Access | Times Cited: 168
Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
Athina Angelopoulou, Nikolaos Alexandris, Evangelia Konstantinou, et al.
Environmental Research (2020) Vol. 188, pp. 109858-109858
Open Access | Times Cited: 81
Resiquimod, a topical drug for viral skin lesions and skin cancer
Thomas Meyer, Christian Surber, Lars E. French, et al.
Expert Opinion on Investigational Drugs (2012) Vol. 22, Iss. 1, pp. 149-159
Closed Access | Times Cited: 81
Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients
Noël Emile Célestin Schartz, Sylvie Chevret, C. Paz, et al.
Journal of the American Academy of Dermatology (2008) Vol. 58, Iss. 4, pp. 585-591
Closed Access | Times Cited: 83
Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod
Maria Lapteva, Margaux Mignot, Karine Mondon, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 553-562
Closed Access | Times Cited: 43
TLRs as a Promise Target Along With Immune Checkpoint Against Gastric Cancer
Lin Cui, Xiuqing Wang, Dekai Zhang
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 37
The role of TLRs (microbe recognition receptor) in gastric cancer: An update
Saade Abdalkareem Jasim, Sumaya Ayad Abdulrazzaq, H. Malathi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects
Laurence Zitvogel, Guido Kroemer
Journal of Clinical Investigation (2009)
Open Access | Times Cited: 63
Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia
Christos Iavazzo, Eleni Pitsouni, Stavros Athanasiou, et al.
International Journal of Gynecology & Obstetrics (2008) Vol. 101, Iss. 1, pp. 3-10
Closed Access | Times Cited: 62
Targeting Aerobic Glycolysis and HIF-1α Expression Enhance Imiquimod-induced Apoptosis in Cancer Cells
Shi‐Wei Huang, Jun‐Kai Kao, Chun‐Ying Wu, et al.
Oncotarget (2014) Vol. 5, Iss. 5, pp. 1363-1381
Open Access | Times Cited: 51
Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer
Emilio Garcia‐Mouronte, Emilio Berna‐Rico, Belén de Nicolás-Ruanes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10835-10835
Open Access | Times Cited: 11
Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses
Elena Campione, Antonia Rivieccio, Ruslana Gaeta Shumak, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1686-1686
Open Access | Times Cited: 11
Imiquimod for the treatment of oral leukoplakia: A two‐center retrospective study
Hervé Sroussi, Alessandro Villa, Malak Al‐Hadlaq, et al.
Oral Diseases (2024)
Closed Access | Times Cited: 3
Emerging immunologic approaches as cancer anti-angiogenic therapies
Mohammadreza Azimi, Mahdokht Sadat Manavi, Maral Afshinpour, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 3
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Xiaodong Wang, Yu Liu, Yuwen Diao, et al.
Journal of Translational Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 27
Dendritic Cells in Cancer
Michael R. Shurin, Russell D. Salter
Springer eBooks (2009)
Closed Access | Times Cited: 32
Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses
Sven Quist, Harald Gollnick
Expert Opinion on Pharmacotherapy (2011) Vol. 12, Iss. 3, pp. 451-461
Closed Access | Times Cited: 28
Make It Simple: (SR-A1+TLR7) Macrophage Targeted NANOarchaeosomes
Federico Parra, Ayelen Tatiana Caimi, María Julia Altube, et al.
Frontiers in Bioengineering and Biotechnology (2018) Vol. 6
Open Access | Times Cited: 22
Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy
Sin-Ting Wang, Shi‐Wei Huang, Jun‐Kai Kao, et al.
Journal of Dermatological Science (2015) Vol. 78, Iss. 2, pp. 108-116
Closed Access | Times Cited: 21
Lupus erythematosus-like imiquimod reaction: a diagnostic pitfall*
Keira Barr, Thomas Konia, Maxwell A. Fung
Journal of Cutaneous Pathology (2010), pp. no-no
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top